London & Capital Glb Eq Opps X GBP H Acc

Performance History30/04/2025
Growth of 1,000 (EUR)
London & Capital Glb Eq Opps X GBP H Acc
Fund--35.412.8-9.5
+/-Cat-----
+/-Idx-----
 
Key Stats
NAV
08/05/2025
 GBP 128.11
Day Change 1.17%
Morningstar Category™ Other Equity
ISIN IE000G94VZU1
Fund Size (Mil)
08/05/2025
 USD 47.93
Share Class Size (Mil)
08/05/2025
 GBP 7.23
Max Initial Charge -
Ongoing Charge
01/01/2023
  0.82%
Investment Objective: London & Capital Glb Eq Opps X GBP H Acc
To seek to provide long-term capital growth through investments in global equities.
Returns
Trailing Returns (EUR)08/05/2025
YTD-7.26
3 Years Annualised-
5 Years Annualised-
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
-
-
Inception Date
25/05/2022
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
MSCI World NR USD-
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  London & Capital Glb Eq Opps X GBP H Acc30/04/2025
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks94.780.0094.78
Bonds0.000.000.00
Cash68.2363.015.23
Other0.000.000.00
Top 5 Regions%
United States85.21
Eurozone5.65
Asia - Developed4.18
Europe - ex Euro3.22
Latin America1.74
Top 5 Sectors%
Technology31.53
Healthcare28.99
Financial Services19.66
Communication Services7.66
Consumer Cyclical7.53
Top 5 HoldingsSector%
Alphabet Inc Class CCommunication ServicesCommunication Services7.26
Cadence Design Systems IncTechnologyTechnology6.88
Intuitive Surgical IncHealthcareHealthcare5.59
Repligen CorpHealthcareHealthcare5.51
Align Technology IncHealthcareHealthcare4.98
London & Capital Glb Eq Opps X GBP H Acc

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookie Settings        Disclosures